BIOQ Bioqual Inc (PK)

Dr. John C. Landon founded BIOQUAL in 1982. He led BIOQUAL for more than 30 years as President and Chief Executive Officer, and grew BIOQUAL to its current position as a $20M+ life sciences corporation.

Effective June 3, 2013, Dr. Mark G. Lewis, BIOQUAL’s President, was also appointed to succeed Dr. Landon as BIOQUAL’s CEO. BIOQUAL’s Board of Directors had appointed Dr. Lewis as BIOQUAL’s President on November 15, 2010, based in part on the belief that Dr. Lewis would be a strong candidate as a successor CEO. Dr. Landon will also retire as an employee of BIOQUAL on August 14, 2013, but will continue as Chairman of the BIOQUAL Board of Directors.

Dr. Lewis joined BIOQUAL as Senior Scientist in August 2003. He became the Executive Vice President in October 2008, and served in that capacity until he became President in 2010.

Dr. Lewis, 58, received his B.A. (1977) degree from Ohio Wesleyan University and his Masters (1980) and Ph.D. (1983) degrees from Ohio State University, Department of Veterinary Pathology. He performed his post-doctoral studies (1983-1984) in the OSU Department of Pharmacology, and continued at OSU as a Research Associate until 1988. From 1988-1991, he was a Staff Virologist at the Southern Research Institute, Frederick, Maryland. From 1991 to 1998, he was a Principal Scientist for the Henry M. Jackson Foundation, Rockville, Maryland. In 1999, Dr. Lewis rejoined the Southern Research Institute as a Staff Scientist, and in 2002 was appointed Acting Director, Senior Scientist.

Since joining BIOQUAL in 2003, Dr. Lewis has been the primary factor in BIOQUAL’s growth in the area of viral infectious diseases and has attracted to BIOQUAL several new commercial and government clients.

Bioqual (PK) (USOTC:BIOQ)
과거 데이터 주식 차트
부터 2월(2) 2025 으로 3월(3) 2025

Bioqual (PK) (USOTC:BIOQ)
과거 데이터 주식 차트
부터 3월(3) 2024 으로 3월(3) 2025